Showing results 1 to 2 of 2
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Polyuria due to vasopressin V2 receptor antagonism is not associated with increased ureter diameter in ADPKD patients Journal:Clinical and Experimental Nephrology | 2017 | ||
Rationale and design of the TEMPO (tolvaptan efficacy and safety in management of autosomal dominant polycystic kidney disease and its outcomes) 3-4 study Journal:American Journal of Kidney Diseases | 2011 |